Primary results from the smartdelay determined AV optimization: A comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: A randomized trial comparing empirical, echocardiography- guided, and algorithmic atrioventricular delay programming in cardiac resynchronization therapy

Circulation

Volumn 122, Issue 25, 2010, Pages 2660-2668

  Ellenbogen, Kenneth A ^a   Gold, Michael R ^b   Meyer, Timothy E ^c   Fernández Lozano, Ignacio ^d   Mittal, Suneet ^e   Waggoner, Alan D ^f   Lemke, Bernd ^g   Singh, Jagmeet P ^h   Spinale, Francis G ^b   Van Eyk, Jennifer E ⁱ   Whitehill, Jeffrey ^j   Weiner, Stanislav ^k   Bedi, Maninder ^l   Rapkin, Joshua ^c   Stein, Kenneth M ^c  

^a VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c Boston Scientific   (United States)

^d HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^e ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g Maerkische Kliniken GmbH   (Germany)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁱ JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j Austin Heart   (United States)

^k Tyler Cardiovascular Consultants   (United States)

^l Washington Hospital   (United States)

more..

Author keywords

clinical trials, randomized; echocardiography; electrophysiology; heart failure; implantable cardioverter defibrillators

Indexed keywords

ADULT; AGED; ALGORITHM; ANALYTIC METHOD; ARTICLE; ATRIOVENTRICULAR DELAY PROGRAMMING; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DEFIBRILLATOR; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

AGED; ALGORITHMS; ATRIOVENTRICULAR NODE; CARDIAC RESYNCHRONIZATION THERAPY; DEFIBRILLATORS, IMPLANTABLE; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; STROKE VOLUME; SYSTOLE; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; WALKING;

EID: 78650700438     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.110.992552     Document Type: Article

References (46)

1. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM; Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140-2150.
2. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappen-berger L, Tavazzi L; Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352: 1539-1549. (Pubitemid 40517094)
3. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, Packer M, Clavell AL, Hayes DL, Ellestad M, Trupp RJ, Underwood J, Pickering F, Truex C, McAtee P, Messenger J; MIRACLE Study Group; Multicenter InSync Randomized Clinical Evaluation. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002; 346:1845-1853.
4. Auricchio A, Stellbrink C, Sack S, Block M, Vogt J, Bakker P, Huth C, Schöndube F, Wolfhard U, Böcker D, Krahnefeld O, Kirkels H; Pacing Therapies in Congestive Heart Failure (PATH-CHF) Study Group. Long-term clinical effect of hemodynamically optimized cardiac resyn-chronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol. 2002;39:2026-2033. (Pubitemid 34628286)
5. Bakker PF, Meijburg HW, de Vries JW, Mower MM, Thomas AC, Hull ML, Robles De Medina EO, Bredée JJ. Biventricular pacing in end-stage heart failure improves functional capacity and left ventricular function. J Interv Card Electrophysiol. 2000;4:395-404.
6. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, Garrigue S, Kappenberger L, Haywood GA, Santini M, Bailleul C, Daubert JC; Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med. 2001; 344:873-880.
7. Linde C, Leclercq C, Rex S, Garrigue S, Lavergne T, Cazeau S, McKenna W, Fitzgerald M, Deharo JC, Alonso C, Walker S, Braunschweig F, Bailleul C, Daubert JC. Long-term benefits of biventricular pacing in congestive heart failure: results from the Multisite Stimulation in Cardio-myopathy (MUSTIC) study. J Am Coll Cardiol. 2002;40:111-118.
8. Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, Canby RC, Schroeder JS, Liem LB, Hall S, Wheelan K; Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators. Combined cardiac resynchronization and implantable car-dioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA. 2003;289:2685-2694.
9. Sinha AM, Filzmaier K, Breithardt OA, Kunz D, Graf J, Markus KU, Hanrath P, Stellbrink C. Usefulness of brain natriuretic peptide release as a surrogate marker of the efficacy of long-term cardiac resynchro-nization therapy in patients with heart failure. Am J Cardiol. 2003; 91:755-758.
10. Theodorakis GN, Flevari P, Kroupis C, Adamopoulos S, Livanis EG, Kostopoulou A, Kolokathis F, Paraskevaidis IA, Leftheriotis D, Kre-mastinos DT. Antiinflammatory effects of cardiac resynchronization therapy in patients with chronic heart failure. Pacing Clin Electrophysiol. 2006;29:255-261.
11. Yu CM, Fung JW, Zhang Q, Chan CK, Chan I, Chan YS, Kong SL, Sanderson JE, Lam CW. Improvement of serum NT-ProBNP predicts improvement in cardiac function and favorable prognosis after cardiac resynchronization therapy for heart failure. J Card Fail. 2005;11: S42-S46.
12. Michelucci A, Ricciardi G, Sofi F, Gori AM, Pirolo F, Pieragnoli P, Giaccardi M, Colella A, Porciani MC, Di Biase L, Padeletti L, Abbate R, Gensini GF. Relation of inflammatory status to major adverse cardiac events and reverse remodeling in patients undergoing cardiac resynchro-nization therapy. J Card Fail. 2007;13:207-210.
13. Auricchio A, Stellbrink C, Block M, Sack S, Vogt J, Bakker P, Klein H, Kramer A, Ding J, Salo R, Tockman B, Pochet T, Spinelli J. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure: the Pacing Therapies for Congestive Heart Failure Study Group: the Guidant Congestive Heart Failure Research Group. Circulation. 1999;99:2993-3001.
14. Auricchio A, Ding J, Spinelli JC, Kramer AP, Salo RW, Hoersch W, KenKnight BH, Klein HU. Cardiac resynchronization therapy restores optimal atrioventricular mechanical timing in heart failure patients with ventricular conduction delay. J Am Coll Cardiol. 2002;39:1163-1169. (Pubitemid 34267420)
15. Inoue N, Ishikawa T, Sumita S, Nakagawa T, Kobayashi T, Matsushita K, Matsumoto K, Ohkusu Y, Taima M, Kosuge M, Uchino K, Kimura K, Umemura S. Long-term follow-up of atrioventricular delay optimization in patients with biventricular pacing. Circ J. 2005;69:201-204.
16. Meisner JS, McQueen DM, Ishida Y, Vetter HO, Bortolotti U, Strom JA, Frater RW, Peskin CS, Yellin EL. Effects of timing of atrial systole on LV filling and mitral valve closure: computer and dog studies. Am J Physiol. 1985;249:H604-H619.
17. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappen-berger L, Klein W, Tavazzi L; CARE-HF Study Steering Committee and Investigators. The CARE-HF study (Cardiac Resynchronisation in Heart Failure study): rationale, design and end-points. Eur J Heart Fail. 2001; 3:481-489.
18. Gorcsan J III, Abraham T, Agler DA, Bax JJ, Derumeaux G, Grimm RA, Martin R, Steinberg JS, Sutton MS, Yu CM. Echocardiography for cardiac resynchronization therapy: recommendations for performance and reporting: a report from the American Society of Echocardiography Dyssynchrony Writing Group endorsed by the Heart Rhythm Society. J Am Soc Echocardiogr. 2008;21:191-213.
19. Gold MR, Niazi I, Giudici M, Leman RB, Sturdivant JL, Kim MH, Yu Y, Ding J, Waggoner AD. A prospective comparison of AV delay programming methods for hemodynamic optimization during cardiac resyn-chronization therapy. J Cardiovasc Electrophysiol. 2007;18:490-496.
20. Stein KM, Ellenbogen KA, Gold MR, Lemke B, Lozano IF, Mittal S, Spinale FG, Van Eyk JE, Waggoner AD, Meyer TE. SmartDelay determined AV optimization: a comparison of AV delay methods used in cardiac resynchronization therapy (SMART-AV): rationale and design. Pacing Clin Electrophysiol. 2010;33:54-63.
21. Stein KM. Clinical trials and response to CRT therapy. In: Ellenbogen KA, Auricchio A, eds. Pacing to Support the Failing Heart. Hoboken, NJ: Wiley-Blackwell; 2008:130-55.
22. Morales MA, Startari U, Panchetti L, Rossi A, Piacenti M. Atrioventric-ular delay optimization by Doppler-derived left ventricular dP/dt improves 6-month outcome of resynchronized patients. Pacing Clin Elec-trophysiol. 2006;29:564-568.
23. Vidal B, Sitges M, Marigliano A, Delgado V, Díaz-Infante E, Azqueta M, Tamborero D, Tolosana JM, Berruezo A, Pérez-Villa F, Paré C, Mont L, Brugada J. Optimizing the programation of cardiac resynchronization therapy devices in patients with heart failure and left bundle branch block. Am J Cardiol. 2007;100:1002-1006. (Pubitemid 47368109)
24. Steendijk P, Tulner SA, Bax JJ, Oemrawsingh PV, Bleeker GB, Van Erven L, Putter H, Verwey HF, Van Der Wall EE, Schalij MJ. Hemody-namic effects of long-term cardiac resynchronization therapy: analysis by pressure-volume loops. Circulation. 2006;113:1295-1304.
25. Hardt SE, Yazdi SH, Bauer A, Filusch A, Korosoglou G, Hansen A, Bekeredjian R, Ehlermann P, Remppis A, Katus HA, Kuecherer HF. Immediate and chronic effects of AV-delay optimization in patients with cardiac resynchronization therapy. Int J Cardiol. 2007;115:318-325.
26. Tournoux FB, Alabiad C, Fan D, Chen AA, Chaput M, Heist EK, Mela T, Mansour M, Reddy V, Ruskin JN, Picard MH, Singh JP. Echocardio-graphic measures of acute haemodynamic response after cardiac resyn-chronization therapy predict long-term clinical outcome. Eur Heart J. 2007;28:1143-1148.
27. Kedia N, Ng K, Apperson-Hansen C, Wang C, Tchou P, Wilkoff BL, Grimm RA. Usefulness of atrioventricular delay optimization using Doppler assessment of mitral inflow in patients undergoing cardiac resyn-chronization therapy. Am J Cardiol. 2006;98:780-785.
28. St John Sutton MG, Plappert T, Abraham WT, Smith AL, DeLurgio DB, Leon AR, Loh E, Kocovic DZ, Fisher WG, Ellestad M, Messenger J, Kruger K, Hilpisch KE, Hill MR; Multicenter InSync Randomized Clinical Evaluation (MIRACLE) Study Group. Effect of cardiac resyn-chronization therapy on left ventricular size and function in chronic heart failure. Circulation. 2003;107:1985-1990.
29. Whinnett ZI, Briscoe C, Davies JE, Willson K, Manisty CH, Davies DW, Peters NS, Kanagaratnam P, Hughes AD, Mayet J, Francis DP. The atrioventricular delay of cardiac resynchronization can be optimized he-modynamically during exercise and predicted from resting measurements. Heart Rhythm. 2008;5:378-386.
30. Valzania C, Eriksson MJ, Boriani G, Gadler F. Cardiac resynchronization therapy during rest and exercise: comparison of two optimization methods. Europace. 2008;10:1161-1169.
31. Zuber M, Toggweiler S, Quinn-Tate L, Brown L, Amkieh A, Erne P. A comparison of acoustic cardiography and echocardiography for optimizing pacemaker settings in cardiac resynchronization therapy. Pacing Clin Electrophysiol. 2008;31:802-811.
32. Jansen AH, Bracke FA, Van Dantzig JM, Meijer A, Van Der Voort PH, Aarnoudse W, Van Gelder BM, Peels KH. Correlation of echo-Doppler optimization of atrioventricular delay in cardiac resynchronization therapy with invasive hemodynamics in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 2006;97:552-557.
33. Kerlan JE, Sawhney NS, Waggoner AD, Chawla MK, Garhwal S, Osborn JL, Faddis MN. Prospective comparison of echocardiographic atrioven-tricular delay optimization methods for cardiac resynchronization therapy. Heart Rhythm. 2006;3:148-154.
34. Sawhney NS, Waggoner AD, Garhwal S, Chawla MK, Osborn J, Faddis MN. Randomized prospective trial of atrioventricular delay programming for cardiac resynchronization therapy. Heart Rhythm. 2004;1:562-567.
35. Auricchio A, Stellbrink C, Butter C, Sack S, Vogt J, Misier AR, Böcker D, Block M, Kirkels JH, Kramer A, Huvelle E; Pacing Therapies in Congestive Heart Failure II Study Group; Guidant Heart Failure Research Group. Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay. J Am Coll Cardiol. 2003;42:2109-2116.
36. Di Pede F, Gasparini G, De Piccoli B, Yu Y, Cuesta F, Raviele A. Hemodynamic effects of atrial septal pacing in cardiac resynchronization therapy patients. J Cardiovasc Electrophysiol. 2005;16:1273-1278.
37. Sogaard P, Egeblad H, Pedersen AK, Kim WY, Kristensen BO, Hansen PS, Mortensen PT. Sequential versus simultaneous biventricular resyn-chronization for severe heart failure: evaluation by tissue Doppler imaging. Circulation. 2002;106:2078-2084.
38. Van Gelder BM, Bracke FA, Meijer A, Lakerveld LJ, Pijls NH. Effect of optimizing the VV interval on left ventricular contractility in cardiac resynchronization therapy. Am J Cardiol. 2004;93:1500-1503.
39. Boriani G, Muller CP, Seidl KH, Grove R, Vogt J, Danschel W, Schuchert A, Djiane P, Biffi M, Becker T, Bailleul C, Trappe HJ. Randomized comparison of simultaneous biventricular stimulation versus optimized interventricular delay in cardiac resynchronization therapy: the Resynchronization for the Hemodynamic Treatment for Heart Failure Management II Implantable Cardioverter Defibrillator (RHYTHM II ICD) study. Am Heart J. 2006;151:1050-1058.
40. Rao RK, Kumar UN, Schafer J, Viloria E, De Lurgio D, Foster E. Reduced ventricular volumes and improved systolic function with cardiac resynchronization therapy: a randomized trial comparing simultaneous biventricular pacing, sequential biventricular pacing, and left ventricular pacing. Circulation. 2007;115:2136-2144.
41. O'Donnell D, Nadurata V, Hamer A, Kertes P, Mohammed W. Long-term variations in optimal programming of cardiac resynchroni-zation therapy devices. Pacing Clin Electrophysiol. 2005;28:S24-S26.
42. Valzania C, Biffi M, Martignani C, Diemberger I, Bertini M, Ziacchi M, Bacchi L, Rocchi G, Rapezzi C, Branzi A, Boriani G. Cardiac resynchro-nization therapy: variations in echo-guided optimized atrioventricular and interventricular delays during follow-up. Echocardiography. 2007;24: 933-939.
43. Abraham WT, Gras D, Yu CM, Guzzo L, Gupta MS; FREEDOM Steering Committee. Rationale and design of a randomized clinical trial to assess the safety and efficacy of frequent optimization of cardiac resynchronization therapy: the Frequent Optimization Study Using the QuickOpt Method (FREEDOM) trial. Am Heart J. 2010; 159:944-948.
44. Abraham WT, Gras D, Yu CM, Calò L, Islam N, Klein N, Alawwa A, Santamaria M, Goodman J, Exner DV, Birgersdotter-Green U, Clyne C, Mortensen P, Gradaus R, Hasan A, Maounis T, Morgan J, Wijetunga M, Sheppard R, Herre J. Results from the FREEDOM Trial: assess the safety and efficacy of frequent optimization of cardiac resynchronization therapy [abstract]. Available at: http://www.hrsonline.org/Sessions/The-Safety-And-Efficacy-Of-Frequent- Optimization-Of-Cardiac-Resynchronization-Therapy.pdf. ScientificProgram/upload/ Results-From-The-Freedom-Trial-Assess- The-Safety-And-Efficacy-Of-Frequent- Optimization-Of-Cardiac-Resynchronization-Therapy.pdf. Accessed October 19, 2010.
45. Leenders GE, Cramer MJ, Bogaard MD, Meine M, Teske AJ, Prinzen FW, Doevendans PA, De Boeck BWL. Acute hemodynamic improvement or acute recoordination: what matters most for long-term response after cardiac resynchronization therapy? Eur Heart J. 2010;31:412.
46. Simon HA. Models of Man: Social and Rational. New York, NY: John Wiley and Sons, Inc; 1957:279.